Emergency Contraception in Romania

July 2013 | 22 pages | ID: E732E1D4210EN
Euromonitor International Ltd

Abstracts

Emergency contraception was an extremely small category in 2012 with almost insignificant value sales, although there are products available in the country, albeit only a few. The main product that can be found in pharmacies was the Postinor pill, manufactured by Bayer, while Escapelle (Gedeon Richter) was recently introduced to the market.

Euromonitor International's Emergency Contraception in Romania report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Emergency Contraception market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Trends
Category Data
  Table 1 Sales of Emergency Contraception: Value 2007-2012
  Table 2 Sales of Emergency Contraception: % Value Growth 2007-2012
  Table 3 Sales of Emergency Contraception: Value 2011-2012
  Table 4 Sales of Emergency Contraception: % Value Growth 2011-2012
  Table 5 Emergency Contraception Company Shares by Value 2008-2012
  Table 6 Emergency Contraception Brand Shares by Value 2009-2012
  Table 7 Forecast Sales of Emergency Contraception: Value 2012-2017
  Table 8 Forecast Sales of Emergency Contraception: % Value Growth 2012-2017
Executive Summary
Growth Slows in All Categories
Rising Sales of OTC and Supplements
Local Players and Multinationals Compete for Market Share
Chemists/pharmacies Has A Predominant Share
Growth Is Expected To Continue As the Market Has Potential
Key Trends and Developments
Demographic Factors Stimulate Growth in Consumer Health
State Regulation Offers No Favours To Consumers Or Producers
Networks of Chained Pharmaceuticals Expand
Increasingly Better Educated Consumers Become More Demanding
the Consumer Health Market Is Highly Concentrated and Competitive
Market Indicators
  Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
  Table 10 Life Expectancy at Birth 2007-2012
Market Data
  Table 11 Sales of Consumer Health by Category: Value 2007-2012
  Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
  Table 13 Consumer Health Company Shares 2008-2012
  Table 14 Consumer Health Brand Shares 2009-2012
  Table 15 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
  Table 16 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
  Table 17 Forecast Sales of Consumer Health by Category: Value 2012-2017
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2010-2012
Definitions
Sources
Summary 2 Research Sources